Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation. (Q54475803)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

multiple sclerosis

0 references

0 references

Martin Krakauer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Finn Sellebjerg

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

L P Ryder

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

I Alsing

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

P E H Jensen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

N Koch-Henriksen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

A Svejgaard

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

P Soelberg Sørensen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

22 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

European Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1291-1298

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19558503%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Drug Insight: interferon treatment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Using measurements of neutralizing antibodies: the challenge of IFN-beta therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

The importance of measuring IFNbeta bioactivity: monitoring in MS patients and the effect of anti-IFNbeta antibodies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Gene expression analysis of interferon-beta treatment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

IFN-beta1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Interferon-beta induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02716.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54475803&oldid=1107796074"